Alamar Biosciences, Inc. (California) (ALMR)
27.42
+2.05
(+8.08%)
USD |
NASDAQ |
Oct 15, 16:00
27.40
-0.02
(-0.07%)
After-Hours: 20:00
Alamar Biosciences Research and Development Expense (Quarterly) : 13.82M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.82M |
| March 31, 2026 | 13.02M |
| Date | Value |
|---|---|
| June 30, 2025 | 8.895M |
| March 31, 2025 | 8.302M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Personalis, Inc. | 16.34M |
| 10X Genomics, Inc. | 56.79M |
| Adaptive Biotechnologies Corp. | 18.30M |
| Champions Oncology, Inc. | 2.344M |
| Medpace Holdings, Inc. | -- |